IFP Advisors Inc Boosts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

IFP Advisors Inc raised its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 2.6% in the 4th quarter, Holdings Channel.com reports. The firm owned 16,227 shares of the healthcare conglomerate’s stock after acquiring an additional 413 shares during the period. IFP Advisors Inc’s holdings in UnitedHealth Group were worth $8,211,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of UNH. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter worth $30,000. RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group in the third quarter worth $37,000. Highline Wealth Partners LLC purchased a new position in shares of UnitedHealth Group in the third quarter worth $55,000. Legacy Investment Solutions LLC purchased a new position in shares of UnitedHealth Group in the third quarter worth $57,000. Finally, DecisionPoint Financial LLC increased its stake in shares of UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after buying an additional 62 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on UNH. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Barclays reduced their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Oppenheimer boosted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $629.32.

Check Out Our Latest Research Report on UnitedHealth Group

UnitedHealth Group Price Performance

UNH opened at $465.58 on Monday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market capitalization of $428.46 billion, a P/E ratio of 30.04, a P/E/G ratio of 1.37 and a beta of 0.61. The company’s 50-day simple moving average is $519.27 and its two-hundred day simple moving average is $560.44. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $5.83 EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.